National Health Investors INC 8-K filings

NYSE
National Health Investors (NHI) released an investor update on May 5, 2025, providing insights into its operations and future outlook.
NYSE
National Health Investors (NHI) has furnished its Supplemental Information for the quarter ended March 31, 2025, which is available on the company's website.
NYSE
National Health Investors (NHI) announced its first quarter 2025 results, exceeding internal expectations and leading to an increase in the company's full-year guidance.
NYSE
National Health Investors (NHI) has appointed Robert W. Chapin, Jr. to its Board of Directors, effective immediately, to fill a newly created seat.
NYSE
National Health Investors (NHI) has released an investor update, providing insights into its portfolio and future outlook.
NYSE
National Health Investors Inc. (NHI) has furnished its supplemental information for the quarter ended December 31, 2024, which is available on the company's website.
NYSE
National Health Investors (NHI) reports a strong Q4 2024, exceeding internal expectations with significant growth in key financial metrics and introduces positive 2025 guidance.
NYSE
Robert Webb, a long-standing member of National Health Investors' Board of Directors, has retired effective immediately after more than 34 years of service.
NYSE
National Health Investors has announced significant changes to its Board of Directors and corporate governance practices to enhance strategic guidance and accountability.
NYSE
National Health Investors has amended its previous 8-K filing to disclose the appointment of Candice W. Todd as Chairperson of the Audit Committee and member of other key committees, effective January 7, 2025.
NYSE
National Health Investors has appointed Candice Todd, a seasoned real estate and finance executive, to its Board of Directors, effective January 1, 2025.
NYSE
National Health Investors (NHI) announced the retirement of its Board Chairman, W. Andrew Adams, effective December 31, 2024, after more than 30 years of service.
NYSE
National Health Investors, a real estate investment trust, released an investor update on November 5, 2024, detailing its business and portfolio.
NYSE
National Health Investors Inc. has furnished its supplemental information for the quarter ended September 30, 2024, as part of its regulatory filings.
NYSE
National Health Investors (NHI) announced its third quarter 2024 results, showing a slight decrease in net income per share and updating its full-year guidance due to tenant liquidity issues.
NYSE
National Health Investors has entered into an amended and restated credit agreement providing a $700 million revolving credit facility and aligned its existing term loan agreement with the new credit terms.
NYSE
National Health Investors has entered into forward sale agreements with several financial institutions for the sale of 2.76 million shares of its common stock.
NYSE
National Health Investors, Inc. (NHI) has released an investor update, providing insights into its operations and financial outlook.
NYSE
National Health Investors Inc. has released its supplemental information for the quarter ended June 30, 2024, which is available on their website.
NYSE
National Health Investors (NHI) reported a strong second quarter, exceeding expectations and leading to an increase in their full-year guidance.
NYSE
National Health Investors held its annual meeting on May 22, 2024, electing three directors, approving executive compensation, and ratifying its auditor.
NYSE
National Health Investors (NHI) has released an investor update detailing its business and financial outlook.
NYSE
National Health Investors Inc. has furnished its supplemental information for the quarter ended March 31, 2024, which is available on their website.
NYSE
National Health Investors reported strong first-quarter 2024 results, exceeding expectations and leading to an increase in their full-year guidance.
NYSE
National Health Investors, Inc. has established change in control severance agreements with its named executive officers, providing financial protection in the event of a change in company ownership.
NYSE
National Health Investors, Inc. (NHI) has released an investor update detailing its portfolio and strategic direction.
NYSE
National Health Investors Inc. has released its supplemental information for the year ending December 31, 2023, which is available on their website.
NYSE
National Health Investors (NHI) announced strong fourth-quarter and full-year 2023 results, exceeding initial guidance and demonstrating significant improvements in key financial metrics.